michael w. naylor, m.d. university of illinois at chicago director, clinical services in...
Post on 13-Dec-2015
215 Views
Preview:
TRANSCRIPT
Psychiatric Consultation in a Psychotropic Medication
Oversight Program for Foster Children: The Illinois Model
Michael W. Naylor, M.D.
University of Illinois at Chicago
Director, Clinical Services in Psychopharmacology
Background
• Historical context– DCFS challenged by federal courts, DOJ
and ACLU• inadequate casework• chaotic and dangerous placements• substandard care
– Illinois violating constitutional rights of children
Background
• Historical context– Chicago Tribune 1995 editorial series:
• DCFS called “the worst child welfare system in America…” and “a cruel, indifferent bureaucracy that harms kids.”
• “system of shame”
Background
• Historical context– Federal court-approved consent decree
(B.H. v Suter, 1991)• DCFS and ACLU agree to collaborate on
system reform plan
State Context
• Psychotropic medication consent– DCFS Rule 325– Clinicians wishing to start a foster child on
a psychotropic medication must obtain consent from the DCFS Guardian
State Context
• DCFS Psychotropic Medication Consent Program– Two components:
• Centralized Psychotropic Medication Consent Line
– Office of the DCFS Guardian• Clinical Services in Psychopharmacology
– University of Illinois at Chicago
State Context
• Centralized Psychotropic Medication Consent Line– Office of the DCFS Guardian
• legal guardian for children committed to the Department
• responsible for providing consent for medical, surgical, and psychiatric treatment
State Context
• Clinical Services in Psychopharmacology– provide independent review for all
psychotropic medication requests– monitor utilization of psychotropic
medications– provide consultation on particularly
complicated cases
State Context
• Clinical Services in Psychopharmacology– notify the Guardian where provider patterns
warrant review– conduct training for DCFS, foster parents and
childcare providers on psychotropic medications
– disseminate information regarding new pharmaceutical developments and alerts
Consent Process
Prescribing Clinician
UIC Research Team
UIC Psychiatric Nurse
UIC Psychiatric Consultant MD
UIC Psychiatric Nurse
DCFS Authorized
Agent
Psychotropic MedicationRequest Form
– name– DCFS ID
Number– date of birth– sex
– race– weight and
height– placement – physician’s
name and specialty
• Demographic information
Psychotropic MedicationRequest Form
• Clinical information– diagnosis– current medications and dosage– symptoms/rationale– requested medication
• dosage and frequency
Consultation
• Three main providers of consultation for clinicians treating foster children:– Clinical Services in Psychopharmacology– DocAssist– Consult for Kids
Clinical Services in Psychopharmacology
• Consultation– consent process
• independent review of the appropriateness of the psychotropic medication consent request
• recommend action to DCFS– approve– deny– modify
Clinical Services in Psychopharmacology
• Consultation– oversight
• formal– high risk prescribers– emergency medication utilization
• informal– feedback from Administrative Case Reviews– concerns expressed by caseworkers, regional nurses,
guardian ad litem, Court Appointed Special Advocates, judges, Office of the DCFS Guardian
Clinical Services in Psychopharmacology
• Consultation– clinical
• clinical concerns that arise in the course of the independent medication review
• MD:MD• review of consent history• chart review• face-to-face
Clinical Services in Psychopharmacology
• Consultation– prior authorization
• provided consultation to HFS vis-à-vis prior authorization for antipsychotic medications and stimulants for children
• DCFS consent for a medication serves as prior authorization for foster children
Clinical Services in Psychopharmacology
• Consultation– systemic
• consult on development of policies, best practice guidelines re: mental health care for foster children
• co-write legislation
Clinical Services in Psychopharmacology
• Consultation– monitoring/QI
• medication utilization patterns– rate of copharmacy with two or more antipsychotics– rate of polypharmacy by age group
• timeliness of consent process• compliance with Rule 325
Impact of Consultation
0 20 40 60 80 100
0.0
00
.05
0.1
00
.15
0.2
0
Months
% R
eq
ue
sts
ParoxetineFluoxetineOther SSRIs
Paroxetine WarningCSP InterventionBlack Box Warning
Consultation
• Illinois DocAssist– established through the joint efforts of the
Department of Healthcare and Family Services, the Department of Human Services – Mental Health, and the University of Illinois at Chicago
– funding support by the Illinois Children’s Mental Health Partnership
Consultation
• Illinois DocAssist– clinical
• quality of treatment for Medicaid funded children with mental illness in the primary care setting
– client – Medicaid funded providers with a focus on primary care
– purpose – improve the identification, diagnosis and treatment of children and youth with mental health issues through consultation, education and referral services
Consultation
• Consult for Kids Program– established by DCFS to provide primary
care clinicians participating in HealthWorks with resources to evaluate foster children in their care for mental health and behavioral concerns
Consultation
• Consult for Kids Program– clinical
• address questions and concerns about a foster child’s emotional, interpersonal, behavioral or cognitive problems
– client – primary care providers– purpose – help primary care providers navigate
a challenging child through the child welfare system
Consultation
• Challenges to effective consultation– “silo-ization”
• duplication of services• lack of coordination
– informing stakeholders of the services– meeting demand for services
top related